TELA Bio (TELA) Income towards Parent Company (2018 - 2026)
TELA Bio (TELA) posted quarterly Income towards Parent Company of -$12.3 million for Q1 2026, down 8.96% year-over-year from -$13.5 million in Q1 2025, and down 37.95% quarter-over-quarter from -$8.9 million in Q4 2025.
TELA Bio (TELA) Income towards Parent Company (2018 - 2026) Analysis & Trends
TELA Bio's Income towards Parent Company history runs 9 years deep, the most recent figure standing at -$12.3 million for Q1 2026.
- In Q1 2026, Income towards Parent Company fell 8.96% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at -$39.7 million (down 695.83% YoY), while the FY2025 annual figure was -$38.7 million, down 550.27% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$12.3 million, down from -$8.9 million in the prior quarter.
- The five-year high for Income towards Parent Company was $29.2 million in Q4 2024, with the low at -$14.0 million in Q4 2023.
- The 5-year median for Income towards Parent Company is -$11.2 million (2022), against an average of -$8.4 million.
- The sharpest annual moves came in 2024 and 2025: Income towards Parent Company jumped 308.22% in 2024, then plunged 130.42% in 2025.
- TELA Bio's Income towards Parent Company stood at -$9.2 million in 2022, then sank by 53.32% to -$14.0 million in 2023, then surged by 308.22% to $29.2 million in 2024, then slumped by 130.42% to -$8.9 million in 2025, then tumbled by 37.95% to -$12.3 million in 2026.
- Business Quant data shows TELA's Income towards Parent Company at -$12.3 million in Q1 2026, -$8.9 million in Q4 2025, and -$8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | TELA Bio | 37.86 Mn | 7.44 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.26 Mn |
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -14.05 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -12.36 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -9.16 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -11.18 Mn |
| Dec 31, 2021 | -7.89 Mn |
| Sep 30, 2021 | -11.32 Mn |